2025 annual financial data
Puma Biotechnology 2025 Net margin
Direct answer
Net margin was 13.62%.
Operating income was 37,299,000 USD and net income was 31,111,000 USD.
Operating cash flow was 41,802,000 USD.
Get free Puma Biotechnology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 228,371,000 USD
- Operating income
- 37,299,000 USD
- Net income
- 31,111,000 USD
- Operating cash flow
- 41,802,000 USD